Schröder S, Wodzynski A, Padberg B
Institut für Immunologie, Pathologie und Molekularbiologie (IPM), Hamburg.
Pathologe. 1996 Nov;17(6):425-32. doi: 10.1007/s002920050181.
Using 8 different monoclonal antibodies, immunohistology was performed on 36 follicular adenomas and on 28 follicular, 34 papillary, 27 medullary and 29 anaplastic carcinomas of the thyroid. The panel of antibodies was directed against broad-spectrum cytokeratins (pan-CK, antibody lu-5), against basic and acid high-molecular-weight CK of types #1, 5, 10 and 14, against basic (#5 and 6) and acid high-molecular-weight CK (#13) and against basic (#7 and #8) and acid low-molecular-weight CK (#19 and #20). With the exception of a large number of anaplastic carcinomas, nearly all other tumours exhibited strong immunoreactivity with antibodies against pan-CK, CK 8 and CK 19. CK 20 expression was exclusively shown for 2 medullary carcinomas. Reactivity for high-molecular-weight CK could only, each time focally, be demonstrated for 14 papillary and 2 follicular carcinomas and for 2 anaplastic carcinomas with partial squamous differentiation. Thirteen anaplastic carcinomas were not decorated by any of the CK antibodies applied. CK 7 staining exceeding the staining of individual cells was observed in 26 papillary cancers. In contrast, such a finding could only be obtained with each one follicular adenoma, medullary carcinoma and anaplastic carcinoma and with 5 follicular carcinomas. These results confirm earlier studies in that CK 20 expression among thyroid tumours is restricted to the neuroendocrine medullary carcinomas and that in a larger percentage of anaplastic thyroid carcinomas an epithelial phenotype can not be demonstrated even upon using broad-spectrum CK antibodies. New is the finding that there exist considerable differences between papillary carcinomas and all other non-papillary thyroid tumours regarding CK 7 expression. This result might be of differential diagnostic value for the distinction of follicular and papillary thyroid neoplasias which sometimes have an overlapping histological pattern.
使用8种不同的单克隆抗体,对36例滤泡性腺瘤以及28例滤泡状癌、34例乳头状癌、27例髓样癌和29例未分化癌进行免疫组织学检查。该抗体组针对广谱细胞角蛋白(泛细胞角蛋白,抗体lu - 5)、针对1、5、10和14型碱性和酸性高分子量细胞角蛋白、针对碱性(5和6型)和酸性高分子量细胞角蛋白(13型)以及针对碱性(7和8型)和酸性低分子量细胞角蛋白(19和20型)。除大量未分化癌外,几乎所有其他肿瘤对泛细胞角蛋白、细胞角蛋白8和细胞角蛋白19抗体均表现出强免疫反应性。仅2例髓样癌显示细胞角蛋白20表达。仅在14例乳头状癌、2例滤泡状癌以及2例有部分鳞状分化的未分化癌中,每次仅能局灶性地证实高分子量细胞角蛋白的反应性。13例未分化癌未被所应用的任何细胞角蛋白抗体标记。在26例乳头状癌中观察到细胞角蛋白7染色超过单个细胞的染色。相比之下,仅在1例滤泡性腺瘤、1例髓样癌、1例未分化癌以及5例滤泡状癌中获得了这样的结果。这些结果证实了早期研究,即甲状腺肿瘤中的细胞角蛋白20表达仅限于神经内分泌髓样癌,并且在较大比例的未分化甲状腺癌中,即使使用广谱细胞角蛋白抗体也无法显示上皮表型。新发现的是,在细胞角蛋白7表达方面,乳头状癌与所有其他非乳头状甲状腺肿瘤之间存在显著差异。这一结果对于区分有时具有重叠组织学模式的滤泡状和乳头状甲状腺肿瘤可能具有鉴别诊断价值。